Astrazenca's pharmaceutical company has announced the recall of its COVID-19 vaccine around the world, reports The Telegraph. This step is an important event in a global pandemic campaign and can affect vaccination strategy in different countries.
Recently, the pharmaceutical giant first acknowledged in court that his vaccine could cause a rare and dangerous side effect.
However, the company states that the recall decision is purely commercial, as the vaccine has been replaced with updated versions intended to combat new coronavirus options.
"Since then, many variants of COVID-19 vaccines have been developed, there is an excess of available renewable vaccines. This has led to a decrease in demand for Vaxuria, which is no longer produced or delivered. Therefore, Astrazenca has made a decision to initiate the recall of registration certificates for the drug."
